February 11, 2025
TOPLINE: In patients with locally advanced rectal cancer who receive neoadjuvant therapy, radiation dose intensification improves pathologic complete response but leads to a small increase in […]
February 10, 2025
Cancer epidemiologists who study diet have long sought to understand the associations between coffee and tea drinking and the risks for a host of cancer types. […]
February 10, 2025
Chimeric antigen receptor (CAR) T-cell therapy has shown efficacy in blood cancers — with six CAR T-cell products now approved by the US Food and Drug […]
February 10, 2025
Advanced prostate cancer incidence and associated mortality rates have been increasing in California since the 2010s, according to the authors of a new study. These concerning […]
February 10, 2025
TOPLINE: In patients with ERBB2-positive metastatic breast cancer (ERBB2+ MBC) and brain metastasis, more than half of deaths were due to central nervous system (CNS)–related causes; […]
February 7, 2025
TOPLINE: A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and […]
February 7, 2025
TOPLINE: Zenocutuzumab demonstrates efficacy in patients with Neuregulin 1 (NRG1) fusion–positive cancer, achieving a 30% response rate across multiple tumor types. The bispecific antibody shows particularly […]
February 7, 2025
An experimental therapeutic human papillomavirus (HPV) vaccine showed promise in inducing regression of precancerous cervical lesions as well as viral clearance in patients with cervical intraepithelial […]
February 6, 2025
TOPLINE: A personalized cancer vaccine targeting neoantigens in high-risk renal cell carcinoma (RCC) demonstrates promising results, with no disease recurrence in any of the nine participants […]